Literature DB >> 18312157

Epidemiology and management of cryptococcal meningitis: developments and challenges.

Read Pukkila-Worley1, Eleftherios Mylonakis.   

Abstract

The significance of cryptococcal infection as a cause of human disease has dramatically evolved in recent years. The objective of this study was to outline the worldwide significance of cryptococcosis and review developments in the management of cryptococcal meningitis. Cryptococcus neoformans var. grubii remains an important cause of disease, particularly in hosts with acquired immunosuppression. Cryptococcus gattii, on the other hand, infects hosts with seemingly normal immune systems and a recent dramatic outbreak in a new ecologic environment highlights the emerging clinical significance of this fungal pathogen. The introduction of new antifungal agents and the adoption of strategies for controlling elevated intracranial pressure in cryptococcal meningitis have added to our therapeutic options. However, the mortality from this infection remains unacceptably high and we are faced with the specific challenges in the management of this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312157     DOI: 10.1517/14656566.9.4.551

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  30 in total

Review 1.  The spectrum of fungi that infects humans.

Authors:  Julia R Köhler; Arturo Casadevall; John Perfect
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Occult pleural cryptococcosis in an immunocompromised patient.

Authors:  S K Kamminga; C Boer; A A Rijkeboer; M A Paul; A Vonk Noordegraaf; R J Strack van Schijndel
Journal:  Intensive Care Med       Date:  2008-11-01       Impact factor: 17.440

Review 3.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

4.  Predictive Model for Permanent Shunting in Cryptococcal meningitis.

Authors:  Woralux Phusoongnern; Siriluck Anunnatsiri; Kittisak Sawanyawisuth; Amnat Kitkhuandee
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

Review 5.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Cryptococcus neoformans activates RhoGTPase proteins followed by protein kinase C, focal adhesion kinase, and ezrin to promote traversal across the blood-brain barrier.

Authors:  Jong-Chul Kim; Benjamin Crary; Yun C Chang; Kyung J Kwon-Chung; Kee J Kim
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

7.  The tetraspanin CD82 is specifically recruited to fungal and bacterial phagosomes prior to acidification.

Authors:  Katerina Artavanis-Tsakonas; Pia V Kasperkovitz; Eliseo Papa; Michael L Cardenas; Nida S Khan; Annemarthe G Van der Veen; Hidde L Ploegh; Jatin M Vyas
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

Review 8.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Transcription factors Mat2 and Znf2 operate cellular circuits orchestrating opposite- and same-sex mating in Cryptococcus neoformans.

Authors:  Xiaorong Lin; Jennifer C Jackson; Marianna Feretzaki; Chaoyang Xue; Joseph Heitman
Journal:  PLoS Genet       Date:  2010-05-13       Impact factor: 5.917

10.  Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action.

Authors:  Brad Tebbets; Zhiguo Yu; Douglas Stewart; Li-Xing Zhao; Yi Jiang; Li-Hua Xu; David Andes; Ben Shen; Bruce Klein
Journal:  Med Mycol       Date:  2012-08-28       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.